Ownership history in CAXTON CORP · 11 quarters on record
This page tracks every 13F SEC filing in which CAXTON CORP reported a position in LEXEO THERAPEUTICS INC (LXEO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 13,943 | -3,389 | -19.6% | 3.24% | $138K | $9.93 |
| 2025 Q3 | UNCHANGED | 17,332 | — | 0% | 0.50% | $115K | $6.64 |
| 2025 Q2 | REDUCED | 17,332 | -519 | -2.9% | 0.71% | $70K | $4.02 |
| 2025 Q1 | UNCHANGED | 17,851 | — | 0% | 1.22% | $61.9M | $3.47 |
As of 2025 Q4 — sorted by position size